Detalhe da pesquisa
1.
Genetic deletion or pharmacologic inhibition of the Nlrp3 inflammasome did not ameliorate experimental NASH.
J Lipid Res
; 64(2): 100330, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36641116
2.
Centrizonal hepatocyte dropout in allograft liver biopsies: a clinicopathological study.
Histopathology
; 80(4): 708-719, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34843118
3.
Perturbation of Wnt/ß-catenin signaling and sexual dimorphism in non-alcoholic fatty liver disease.
Hepatol Res
; 52(5): 433-448, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35120274
4.
Neutrophilic inflammation in gallbladder carcinoma correlates with patient survival: A case-control study.
Ann Diagn Pathol
; 56: 151845, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34763224
5.
Comparing the clinicopathological characteristics of combined hepatocellular-cholangiocarcinoma with those of other primary liver cancers by use of the updated World Health Organization classification.
Histopathology
; 79(4): 556-572, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33837585
6.
S100P as a marker for poor survival and advanced stage in gallbladder carcinoma.
Ann Diagn Pathol
; 52: 151736, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33798925
7.
Non-alcoholic fatty liver disease: A review with clinical and pathological correlation.
J Formos Med Assoc
; 120(1 Pt 1): 68-77, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32654868
8.
A Review on the Update of Combined Hepatocellular Cholangiocarcinoma.
Semin Liver Dis
; 40(2): 124-130, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31887773
9.
Exercise retards hepatocarcinogenesis in obese mice independently of weight control.
J Hepatol
; 73(1): 140-148, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32302728
10.
Mouse Models of Nonalcoholic Steatohepatitis: Toward Optimization of Their Relevance to Human Nonalcoholic Steatohepatitis.
Hepatology
; 69(5): 2241-2257, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30372785
11.
Immune-related adverse reactions in the hepatobiliary system: second-generation check-point inhibitors highlight diverse histological changes.
Histopathology
; 76(3): 470-480, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31550390
12.
Prevalence, risk factors, and surveillance patterns for gastric intestinal metaplasia among patients undergoing upper endoscopy with biopsy.
Gastrointest Endosc
; 91(1): 70-77.e1, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31425693
13.
Loss of nectin-3 expression as a marker of tumor aggressiveness in pancreatic neuroendocrine tumor.
Pathol Int
; 70(2): 84-91, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31855317
14.
Knowledge gaps in the appendix: a multi-institutional study from seven academic centers.
Mod Pathol
; 32(7): 988-996, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30765881
15.
Checkpoint inhibitor-induced liver injury: A novel form of liver disease emerging in the era of cancer immunotherapy.
Semin Diagn Pathol
; 36(6): 434-440, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31358424
16.
Update on the pathology of liver neoplasms.
Ann Diagn Pathol
; 38: 126-137, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30597357
17.
Hepatotoxicity of immune checkpoint inhibitors: a histology study of seven cases in comparison with autoimmune hepatitis and idiosyncratic drug-induced liver injury.
Mod Pathol
; 31(6): 965-973, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29403081
18.
Molecular testing for the clinical diagnosis of fibrolamellar carcinoma.
Mod Pathol
; 31(1): 141-149, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28862261
19.
Increased expression of senescence-associated cell cycle regulators in the progression of biliary atresia: an immunohistochemical study.
Histopathology
; 72(7): 1164-1171, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29392752
20.
Data set for the reporting of intrahepatic cholangiocarcinoma, perihilar cholangiocarcinoma and hepatocellular carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR).
Histopathology
; 73(3): 369-385, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29573451